Siemens Medical Solutions USA, Inc. and Consolidated Subsidiaries

United States Tax Court·Decided July 15, 2026·No. 11432-25·Published

Opinion

United States Tax Court

REVIEWED 167 T.C. No. 5

SIEMENS MEDICAL SOLUTIONS USA, INC. AND CONSOLIDATED SUBSIDIARIES, Petitioner

v.

COMMISSIONER OF INTERNAL REVENUE, Respondent

Held: P is entitled to the full DRD under I.R.C.

§ 245A.

Held, further, Temp. Treas. Reg. § 1.245A-5T does not alter this conclusion because it cannot contravene the clear statutory text.

KERRIGAN, J., wrote the opinion of the Court, which URDA, C.J., and BUCH, NEGA, PUGH, ASHFORD, COPELAND, JONES, TORO, GREAVES, MARSHALL, WEILER, WAY, LANDY, ARBEIT, GUIDER, and FUNG, JJ., joined.

JENKINS, J., did not participate in the consideration of this opinion.

Extraordinary Disposition Rules, which are part of the section 245A temporary regulations. See T.D. 9865, 2019-27 I.R.B. 27, 30.

In its Motion petitioner moves for summary judgment because the deficiencies that respondent determined rest on the application of a regulation that petitioner contends is invalid as a matter of law. Respondent seeks summary adjudication that the Extraordinary Disposition Rules are valid.

For the reasons discussed below, we hold that the Extraordinary Disposition Rules cannot contravene the plain meaning of section 245A. Accordingly, we will grant petitioner’s Motion and deny respondent’s Cross-Motion.

Background

The facts set out are derived from the parties’ pleadings and Motion papers. See Rule 121(c)(1). They are stated solely for the purpose of deciding the pending Motion and are not findings of fact for this case. See Sundstrand Corp. v. Commissioner, 98 T.C. 518, 520 (1992), aff’d, 17 F.3d 965 (7th Cir. 1994).

Petitioner, Siemens Medical Solutions USA, Inc., is a wholly owned subsidiary of Siemens Healthineers AG (SHAG), a German company that provides healthcare products globally. Its principal place of business was Pennsylvania when its Petition was timely filed. At all relevant times, Siemens Healthcare Diagnostics, Inc. (SHD US), a California corporation and member of petitioner’s U.S. consolidated group, owned 67.78% of Siemens Medical Solutions Diagnostics Holding I.B.V. (SMS BVI), a Dutch company treated as a corporation for U.S. federal income tax purposes.

During the tax year ended September 30, 2018 (2018 Tax Year), certain foreign subsidiaries of SMS BVI were restructured. On April 1, 2018, SMS BVI sold 100% of Siemens Healthcare Diagnostics GmbH, a Swiss company, for €85,715,399 to Siemens Healthineers Holding III BV, a Dutch company within the SHAG Group (SHAG and its subsidiaries).

On August 13, 2018, SMS BVI sold 100% of Siemens Healthcare Diagnostics Holding GmbH, a German company, to Siemens Healthcare GmbH, a German company within the SHAG Group, for €1,339,593,000. As a result of these two sales, SMS BVI increased its earnings and profits (E&P) by approximately €819,000,000.

On March 19, 2019, SMS BVI made a pro rata distribution of €1,750,000,000 to its shareholders (March 2019 Distribution). Since SHD US owned 67.78% of SMS BVI, it received 67.78% of the March 2019 Distribution which was €1,186,073,740. Of that amount $670,616,109 was a dividend made out of SMS BVI’s E&P (March 2019 Dividend). The March 2019 Dividend was entirely foreign source.

Petitioner timely filed consolidated federal income tax returns for its 2019 Tax Year and its 2021 Tax Year. On its Form 1120, U.S. Corporation Income Tax Return, for its 2019 Tax Year, petitioner claimed a deduction for the full amount of the March 2019 Dividend. When preparing its tax return for the 2019 Tax Year, petitioner considered the implications of the Extraordinary Disposition Rules, and it concluded that its two sales that occurred in 2018 “likely” fit the definition of “extraordinary dispositions” under those rules. Of the March 2019 Dividend, $40,630,184 was not attributable to the two sales occurring in 2018. If the Extraordinary Disposition Rules apply, a deduction for $314,992,962 of the March 2019 Dividend would be disallowed.

Petitioner concluded that the Extraordinary Disposition Rules were invalid and that it was entitled to the full section 245A deduction. It filed Form 8275–R, Regulation Disclosure Statement, with its tax return for its 2019 Tax Year. On its Form 8275–R, petitioner disclosed the relevant facts and its legal analysis supporting its position that the Extraordinary Disposition Rules are invalid.

In the Notice of Deficiency respondent determined deficiencies of $5,581,518 and $1,452,006 for the 2019 Tax Year and the 2021 Tax Year, respectively. Respondent disallowed $314,992,962 of the section 245A deduction.

Discussion

I. Summary Judgment

The purpose of summary judgment is to expedite litigation and avoid costly, time-consuming, and unnecessary trials. Fla. Peach Corp. v. Commissioner, 90 T.C. 678, 681 (1988). Under Rule 121(a), either party may move for summary judgment regarding all or any part of the legal issues in controversy. We may grant summary judgment only if there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law. Rule 121(a)(2); Sundstrand Corp., 98 T.C. at 520. The moving party bears the burden of

demonstrating that there is no genuine dispute as to any material fact. FPL Grp., Inc. & Subs. v. Commissioner, 116 T.C. 73, 74–75 (2001). In deciding whether to grant summary judgment, we construe factual materials and inferences drawn from them in the light most favorable to the adverse party. Sundstrand Corp., 98 T.C. at 520.

There is no material dispute of fact, and we may resolve the Motions as a matter of law.

II. Background Law

A. Overview

The United States taxes its citizens and domestic corporations on worldwide income. See, e.g., Cook v. Tait, 265 U.S. 47, 56 (1924); Huff v. Commissioner, 135 T.C. 222, 230 (2010). In 1962 Congress enacted subpart F in response to erosion of the U.S. tax base. See Dougherty v. Commissioner, 60 T.C. 917, 928 (1973) (“In subpart F, Congress has singled out a particular class of taxpayers, U.S. shareholders, whose degree of control over their foreign corporation allows them to treat the corporation’s undistributed earnings as they see fit.” (footnote omitted)). The goal of subpart F is to tax currently specified earnings of controlled foreign corporations (CFCs) that are in the aggregate controlled by U.S. shareholders. Textron Inc. & Subs. v. Commissioner, 117 T.C. 67, 73– 74 (2001). Subpart F applies only to a small portion of the CFC’s income, mostly passive income. See Moore v. United States, 144 S. Ct. 1680, 1685 (2024).

Since its enactment, the effectiveness of subpart F has been questioned. Generally, the U.S. tax on a CFC’s income, not subject to subpart F, is deferred until the income is repatriated in the form of a dividend or other distribution to the CFC’s U.S. shareholders. §§ 881, 882; see also Dave Fischbein Mfg. Co. v. Commissioner, 59 T.C. 338, 353 (1972); S. Rep. No. 87-1881, at 78 (1962), reprinted in 1962-3 C.B. 703, 784. A 2000 Department of the Treasury Policy Study raised concerns that subpart F and the current antideferral system were not preventing erosion of the U.S. tax base. See U.S. Dep’t of the Treasury, Off. of Tax Pol’y, The Deferral of Income Earned Through U.S. Controlled Foreign Corporations (2000), https://home.treasury.gov/system/files/131/Report- SubpartF-2000.pdf.

In 2017 Congress enacted the Tax Cuts and Jobs Act (TCJA), Pub. L. No. 115-97, 131 Stat. 2054 (2017). The TCJA “altered the United States’ approach to international corporate taxation” with the goal of

encouraging “Americans who controlled foreign corporations to invest earnings from their foreign investments back in the United States instead of abroad.” Moore, 144 S. Ct. at 1685–86.

Free access — add to your briefcase to read the full text and ask questions with AI

Siemens Medical Solutions USA, Inc. and Consolidated Subsidiaries, (tax 2026).

Siemens Medical Solutions USA, Inc. and Consolidated Subsidiaries (Siemens Medical Solutions USA, Inc. and Consolidated Subsidiaries) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Cook v. Tait
265 U.S. 47 (Supreme Court, 1924)
Davis v. Michigan Department of the Treasury
489 U.S. 803 (Supreme Court, 1989)
Connecticut National Bank v. Germain
503 U.S. 249 (Supreme Court, 1992)
Michigan v. EPA
576 U.S. 743 (Supreme Court, 2015)
In Re the Complaint of Nautilus Motor Tanker Co.
85 F.3d 105 (Third Circuit, 1996)
Wisconsin Central Ltd. v. United States
585 U.S. 274 (Supreme Court, 2018)
Pereira v. Sessions
585 U.S. 198 (Supreme Court, 2018)
Huff v. Commissioner
135 T.C. No. 10 (U.S. Tax Court, 2010)
FPL Group, Inc. v. Commissioner
116 T.C. No. 7 (U.S. Tax Court, 2001)
Textron Inc. v. Comm'r
117 T.C. No. 7 (U.S. Tax Court, 2001)
Dave Fischbein Mfg. Co. v. Commissioner
59 T.C. 338 (U.S. Tax Court, 1972)
Dougherty v. Commissioner
60 T.C. No. 97 (U.S. Tax Court, 1973)
Florida Peach Corp. v. Commissioner
90 T.C. No. 41 (U.S. Tax Court, 1988)
Sundstrand Corp. v. Commissioner
98 T.C. No. 36 (U.S. Tax Court, 1992)
Monssef Cheneau v. Merrick Garland
997 F.3d 916 (Ninth Circuit, 2021)
Sossamon v. Texas
179 L. Ed. 2d 700 (Supreme Court, 2011)